304 related articles for article (PubMed ID: 31910092)
1. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
[No Abstract] [Full Text] [Related]
2. Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.
Shih P; Nickel B; Degeling C; Thomas R; Brito JP; McLeod DSA; McCaffery K; Carter SM
Thyroid; 2021 Jul; 31(7):1067-1075. PubMed ID: 33238815
[No Abstract] [Full Text] [Related]
3. Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons.
Or K; Benbassat C; Koren S; Shteinshneider M; Koren R; Cantrell D; Kummer E; Muallem Kalmovich L
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2851-2859. PubMed ID: 30229453
[TBL] [Abstract][Full Text] [Related]
4. Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US.
Dedhia PH; Saucke MC; Long KL; Doherty GM; Pitt SC
JAMA Netw Open; 2022 Apr; 5(4):e228722. PubMed ID: 35467735
[TBL] [Abstract][Full Text] [Related]
5. Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
Nickel B; Brito JP; Barratt A; Jordan S; Moynihan R; McCaffery K
Thyroid; 2017 May; 27(5):661-671. PubMed ID: 28322617
[TBL] [Abstract][Full Text] [Related]
6. Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
Kaliszewski K; Diakowska D; Wojtczak B; Rudnicki J
PLoS One; 2020; 15(7):e0236257. PubMed ID: 32692768
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
Jensen CB; Saucke MC; Pitt SC
BMC Cancer; 2021 Apr; 21(1):471. PubMed ID: 33910527
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
McDow AD; Roman BR; Saucke MC; Jensen CB; Zaborek N; Jennings JL; Davies L; Brito JP; Pitt SC
Am J Surg; 2021 Jul; 222(1):111-118. PubMed ID: 33248684
[TBL] [Abstract][Full Text] [Related]
9. NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.
Roman BR; Brito JP; Saucke MC; Lohia S; Jensen CB; Zaborek N; Jennings JL; Tuttle RM; Davies L; Pitt SC
Endocr Pract; 2021 Jan; 27(1):1-7. PubMed ID: 33471727
[TBL] [Abstract][Full Text] [Related]
10. Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
Krajewska J; Kukulska A; Oczko-Wojciechowska M; Kotecka-Blicharz A; Drosik-Rutowicz K; Haras-Gil M; Jarzab B; Handkiewicz-Junak D
Front Endocrinol (Lausanne); 2020; 11():571421. PubMed ID: 33123090
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
[TBL] [Abstract][Full Text] [Related]
12. Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.
Nickel B; Semsarian C; Moynihan R; Barratt A; Jordan S; McLeod D; Brito JP; McCaffery K
BMJ Open; 2019 Feb; 9(2):e025820. PubMed ID: 30813118
[TBL] [Abstract][Full Text] [Related]
13. Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.
Nickel B; Brito JP; Moynihan R; Barratt A; Jordan S; McCaffery K
BMC Cancer; 2018 Mar; 18(1):242. PubMed ID: 29499654
[TBL] [Abstract][Full Text] [Related]
14. Progress and Challenges in Thyroid Cancer Management.
Haymart MR
Endocr Pract; 2021 Dec; 27(12):1260-1263. PubMed ID: 34562612
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
[No Abstract] [Full Text] [Related]
16. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
17. [Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomas].
Staubitz JI; Musholt TJ
Pathologe; 2019 Dec; 40(Suppl 3):342-346. PubMed ID: 31705233
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
[TBL] [Abstract][Full Text] [Related]
19. Endocrinologist-Perceived Factors Affecting the Transition of Thyroid Cancer Patients from Specialist to Primary Care Postcancer Treatment in Ontario, Canada.
Janmohamed N; Segal P; Corrado AM; Lofters A; Nguyen P; Townsley C; Zahedi A
Thyroid; 2021 Jun; 31(6):895-901. PubMed ID: 33121388
[No Abstract] [Full Text] [Related]
20. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
Ullmann TM; Papaleontiou M; Sosa JA
J Clin Endocrinol Metab; 2023 Jan; 108(2):271-280. PubMed ID: 36327392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
